{"product_id":"clinical-guide-to-transplantation-in-lymphoma-isbn-9781118863329","title":"Clinical Guide to Transplantation in Lymphoma","description":"The first book on clinical guide to transplantation in lymphoma to present cutting edge knowledge on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies\u003cbr\u003e \u003cul\u003e \u003cli\u003eProvides practical management guidance on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies\u003c\/li\u003e \u003cli\u003eCovers an overview of transplantation in lymphoma, and management of the lymphoid malignancies\u003c\/li\u003e \u003cli\u003eDiscusses organizational aspects of transplant patients and managing a transplant program\u003c\/li\u003e \u003cli\u003eAppendices provide practical quick-reference information on follow-up after autologous and allogenic stem cell transplantation in lymphoma\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eList of contributors vii\u003c\/p\u003e \u003cp\u003eForeword xi\u003c\/p\u003e \u003cp\u003eIntroduction 1\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1: Transplantation in lymphomas\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Lymphoma and transplantation: historical perspective 5\u003cbr\u003e\u003ci\u003eAndrew R. Rezvani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Lymphoma: working committee and data reporting after transplantation in lymphoma 13\u003cbr\u003e\u003ci\u003eWael Saber, Mehdi Hamadani, Shahrukh Hashmi\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Parameswaran Hari\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Use of transplantation in lymphoma: adults 23\u003cbr\u003e\u003ci\u003eParastoo Bahrami Dahi, Gabriela Soriano Hobbs\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Miguel\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eAngel Perales\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Hematopoietic stem cell transplantation for lymphoma in children, adolescents, and young adults 31\u003cbr\u003e\u003ci\u003eNader Kim El\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eMallawany and Mitchell S. Cairo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Preparative regimens for lymphoma: autologous hematopoietic stem cell transplantation 45\u003cbr\u003e\u003ci\u003eTaiga Nishihori, Karma Z. Salem, Ernesto Ayala\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Mohamed A. Kharfan\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eDabaja\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Preparative regimens for lymphoma: allogeneic hematopoietic stem cell transplantation 57\u003cbr\u003e\u003ci\u003eMohamed A. Kharfan\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eDabaja, Najla El\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eJurdi,\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eMehdi Hamadani and Ernesto Ayala\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Pretransplantation evaluation, comorbidities, and nondisease]related eligibility criteria for transplantation in lymphoma, 69\u003cbr\u003e\u003ci\u003eMelissa Logue\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Stem cell mobilization in lymphoma patients 75\u003cbr\u003e\u003ci\u003eTarah Ballinger, Bipin N. Savani\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Mohamad Mohty\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Allogeneic hematopoietic stem cell transplantation for lymphoma: stem cell source, donor, and HLA matching 85\u003cbr\u003e\u003ci\u003eMichael Green and Mitchell Horwitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Management of early and late toxicities of autologous hematopoietic stem cell transplantation 93\u003cbr\u003e\u003ci\u003eSai Ravi Pingali and Yago Nieto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Long]term follow]up of lymphoma patients after allogeneic hematopoietic cell transplantation 103\u003cbr\u003e\u003ci\u003eShylaja Mani and Navneet S. Majhail\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 First 100 days of the autologous hematopoietic stem cell transplantation process in lymphoma 109\u003cbr\u003e\u003ci\u003eAngela Moreschi Woods\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 First 100 days of the allogeneic hematopoietic stem cell transplantation process in lymphoma 113\u003cbr\u003e\u003ci\u003eAngela Moreschi Woods\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Management\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e14 Stem cell transplantation in follicular lymphoma,119\u003cbr\u003e\u003ci\u003eSatyajit Kosuri and Koen Van Besien\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Chronic lymphocytic leukemia\/small lymphocytic lymphoma 133\u003cbr\u003e\u003ci\u003eSalyka Sengsayadeth and Wichai Chinratanalab\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Diffuse large B]cell lymphoma 145\u003cbr\u003e\u003ci\u003eLauren Veltri, Bipin N. Savani\u003c\/i\u003e\u003ci\u003e, \u003c\/i\u003e\u003ci\u003eMohamed A. Kharfan\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eDabaja, Mehdi Hamadani\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Abraham S. Kanate\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Mantle cell lymphoma 161\u003cbr\u003e\u003ci\u003eSascha Dietrich and Peter Dreger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Hodgkin lymphoma 173\u003cbr\u003e\u003ci\u003eEva Domingo\u003c\/i\u003e\u003ci\u003e]\u003c\/i\u003e\u003ci\u003eDomenech and Anna Sureda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Peripheral T]cell lymphomas 187\u003cbr\u003e\u003ci\u003eGiulia Perrone, Chiara De Philippis, Lucia Farina\u003c\/i\u003e\u003ci\u003e \u003c\/i\u003e\u003ci\u003eand Paolo Corradini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Transplantation in Burkitt and lymphoblastic lymphoma 201\u003cbr\u003e\u003ci\u003eGregory A. Hale\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Transplantation in adult T]cell leukemia\/lymphoma 209\u003cbr\u003e\u003ci\u003eAli Bazarbachi and Olivier Hermine\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Hematopoietic cell transplantation for HIV]related lymphomas 217\u003cbr\u003e\u003ci\u003eJoseph C. Alvarnas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Stem cell transplantation for mycosis fungoides\/Sézary syndrome 233\u003cbr\u003e\u003ci\u003eEric D. Jacobsen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Role of transplantation in lymphoplasmacytic lymphoma 241\u003cbr\u003e\u003ci\u003eSilvia Montoto and Charalampia Kyriakou\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Transplantation outcome in primary mediastinal large B]cell lymphoma 247\u003cbr\u003e\u003ci\u003eAmanda F. Cashen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Management of post]transplant lymphoproliferative disorders 253\u003cbr\u003e\u003ci\u003eJan Styczynski and Per Ljungman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAppendix I Follow]up calendar after autologous stem cell transplantation in lymphoma 261\u003cbr\u003e\u003ci\u003eAngela Moreschi Woods\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAppendix II Follow]up calendar after allogeneic stem cell transplantation in lymphoma 263\u003cbr\u003e\u003ci\u003eAngela Moreschi Woods\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 265\u003c\/p\u003e Sir William Osler is reputed to have said, “Listen to the patient and he will give you the answer.” Had he been alive now and practicing transplantation for lymphoma, he could have well said “Read the \u003ci\u003eClinical Guide to Transplantation in Lymphoma\u003c\/i\u003e and it will give you the answer.” These reviewers are very impressed by the breadth and scope of this book edited by Drs. Bipin Savani and Mohamed Mohty, ably aided by an array of expert contributors from all over the world.\u003cbr\u003e\u003cbr\u003e\u003ci\u003eClinical Guide to Transplantation in Lymphoma\u003c\/i\u003e is extremely easy to read and very well written. In this era of\u003cbr\u003eexponential information growth this book is surprisingly current, with the latest references. It has an ambitious scope, setting out to cover all aspects of transplantation in lymphoma and managing to meet that expectation.\u003cbr\u003e\u003cbr\u003eChapters are laid out in logical sequence divided into 2 sections. Section 1 is particularly interesting and has\u003cbr\u003echapters on the historical perspective of transplantation for lymphoma, transplant data collection and reporting, and analytical methods. The remainder of section 1 describes the general principles of transplantation in lymphomas, addressing issues such as mobilization, preparative regimens, and management of the early, late, and long-term issues arising after transplantation. Some chapters include transplantation for lymphoma in children, adults, and young adolescents; pretransplant evaluation; preparative regimens for autologous and allogeneic transplants; stem cell mobilization and stem cell source; post-transplant follow-up for autologous\u003cbr\u003eand allogeneic transplant, and a novel chapter, “First 100 Days of the Autologous Hematopoietic Stem Cell Transplantation Process in Lymphoma.” The chapters in section 1 are broadly applicable and would prove invaluable to trainees pursuing fellowships in hematopoietic cell transplantation.\u003cbr\u003e\u003cbr\u003eSection 2 is laid out as a chapter by chapter discussion of various lymphoma histologies and the applicability of hematopoietic cell transplantation in each. One can return to some of these chapters again and again because all common and most rare lymphoma subtypes (including HIV-associated lymphoma) are discussed in excellent detail. We found each one of these chapters to be remarkably up to date. In a field such ashematopoietic cell transplantation,where there is considerable ambiguity and few randomized studies, the authors and editors have maintained a neutral and unbiased tone,discussing the available data andguidelines exhaustively.\u003cbr\u003e\u003cbr\u003eVery few similar textbooks focus on transplantation in a disease group. \u003ci\u003eClinical Guide to Transplantation in Lymphoma\u003c\/i\u003e is concise enough, practical, and clinically oriented to be considered a practical manual but at the same time manages to be comprehensive. Some unique features in this book are the numerous excellent graphs and tables and the discussion of case studies and clinical guidelines (United States and European) wherever applicable. We found very few typographic errors. For future editions we recommend at least 1 chapter devoted to the emerging field of cellular immunotherapy.\u003cbr\u003e\u003cbr\u003eThe editors and the contributors need to be congratulated for an encyclopedic work that still manages to be a ready reference guide. This book will be used extensively and should be in the library of every transplanter.We hope it runs into many future editions and becomes the authoritative textbook for transplantation in lymphoma. (\u003cb\u003eYogesh Jethava, Parameswaran Hari\u003c\/b\u003e, University of Arkansas for Medical Science, \u003ci\u003eBiology of Blood and Marrow Transplantation\u003c\/i\u003e, Nov 2015) \u003cp\u003e\u003cb\u003eBipin N. Savani\u003c\/b\u003e is Professor of Medicine and Director, Long Term Transplant Clinic, Division of Hematology\/Oncology at Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center\u003cbr\u003eNashville, TN, USA\u003cbr\u003e\u003cbr\u003e\u003cb\u003eMohamad Mohty\u003c\/b\u003e is Head, Clinical Hematology and Cellular Therapy Department at Université Pierre \u0026amp; Marie Curie, Hospital Saint Antoine, INSERM, U938, Paris, France\u003c\/p\u003e \u003cp\u003eThis new book provides cutting edge information for transplantation in lymphoma from a clinical perspective. With 26 chapters and over 50 international contributors this title offers a single reference for physicians on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies.\u003c\/p\u003e \u003cp\u003eSection one provides an overview of transplantation in lymphoma, including the historical perspective, role of lymphoma working committees, current use of transplantation in children and adults, the variety of conditioning regimens for auto and allo-HSCT, pre-transplant evaluation, stem cell mobilizations, donor search for patients needing allo-HSCT, and management of long term complications after HSCT for lymphomas. Section two covers management of the lymphoid malignancies, focusing on standard of care transplant management, timing and preparing patients for transplantation, management of post- transplant relapses and most importantly discussion on novel therapies and their integration in transplantation for lymphomas.\u003c\/p\u003e \u003cp\u003eThe appendices provide a quick reference checklist on follow-up after autologous and allogenic stem cell transplantation in lymphoma.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eProvides practical management guidance on how to integrate, transplantation and novel therapies in patients with lymphoid malignancies\u003c\/li\u003e \u003c\/ul\u003e \u003cul\u003e \u003cli\u003eCovers an overview of transplantation in lymphoma, and management of the lymphoid malignancies\u003c\/li\u003e \u003c\/ul\u003e \u003cul\u003e \u003cli\u003eDiscusses organizational aspects of transplant patients and managing a transplant program\u003c\/li\u003e \u003c\/ul\u003e \u003cul\u003e \u003cli\u003eAppendices provide handy quick-reference information on follow-up after autologous and allogenic stem cell transplantation in lymphoma\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e This title is of use for transplant clinicians, oncologists, and haematologists.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47988932804837,"sku":"NP9781118863329","price":142.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118863329.jpg?v=1761782106","url":"https:\/\/k12savings.com\/products\/clinical-guide-to-transplantation-in-lymphoma-isbn-9781118863329","provider":"K12savings","version":"1.0","type":"link"}